Flavio Salazar‐Onfray

4.0k total citations
83 papers, 3.3k citations indexed

About

Flavio Salazar‐Onfray is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Flavio Salazar‐Onfray has authored 83 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Immunology, 30 papers in Oncology and 29 papers in Molecular Biology. Recurrent topics in Flavio Salazar‐Onfray's work include Immunotherapy and Immune Responses (47 papers), Immune Cell Function and Interaction (26 papers) and Cancer Immunotherapy and Biomarkers (20 papers). Flavio Salazar‐Onfray is often cited by papers focused on Immunotherapy and Immune Responses (47 papers), Immune Cell Function and Interaction (26 papers) and Cancer Immunotherapy and Biomarkers (20 papers). Flavio Salazar‐Onfray collaborates with scholars based in Chile, Sweden and United Kingdom. Flavio Salazar‐Onfray's co-authors include Mercedes López, Rolf Kiessling, Ariadna Mendoza‐Naranjo, Max Petersson, Cristián Pereda, María Alejandra Gleisner, Andrés Tittarelli, Fermín E. González, Giuseppe Masucci and Koji Kono and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Clinical Cancer Research.

In The Last Decade

Flavio Salazar‐Onfray

78 papers receiving 3.2k citations

Peers

Countries citing papers authored by Flavio Salazar‐Onfray

Since Specialization

Citations

This map shows the geographic impact of Flavio Salazar‐Onfray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Flavio Salazar‐Onfray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Flavio Salazar‐Onfray more than expected).

Fields of papers citing papers by Flavio Salazar‐Onfray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Flavio Salazar‐Onfray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Flavio Salazar‐Onfray. The network helps show where Flavio Salazar‐Onfray may publish in the future.

Co-authorship network of co-authors of Flavio Salazar‐Onfray

This figure shows the co-authorship network connecting the top 25 collaborators of Flavio Salazar‐Onfray. A scholar is included among the top collaborators of Flavio Salazar‐Onfray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Flavio Salazar‐Onfray. Flavio Salazar‐Onfray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TRIMELVax: A Novel Innate Immune-Engaging Vaccine for Malignant Melanoma Targeting Neutrophil-Driven Antigen Presentation and T-Cell Activation 2025 ·Flavio Salazar‐Onfray	0
2	Glycosylated Delphinidins Decrease Chemoresistance to Temozolomide by Regulating NF-κB/MGMT Signaling in Glioblastoma 2025 ·Cells ·(unknown), (unknown), (unknown), (unknown), (unknown), J. L. Zubieta, (unknown), Juan P. Muñoz, María Alejandra Gleisner, Flavio Salazar‐Onfray, Noemí Garcia‐Romero, Ángel Ayuso‐Sacido, Rody San Martín, (unknown)	0
3	Tumor hypoxia shapes natural killer cell anticancer activities 2025 ·Journal of Molecular Medicine ·Mauricio A. Retamal, Flavio Salazar‐Onfray, Fermín E. González, Andrés Tittarelli	1
4	Long-Term Survival and Immune Response Dynamics in Melanoma Patients Undergoing TAPCells-Based Vaccination Therapy 2024 ·Vaccines ·Andrés Tittarelli, Cristián Pereda, María Alejandra Gleisner, Mercedes López, (unknown), Fabián Tempio, Álvaro Lladser, Adnane Achour, Fermín E. González, Claudia Duran‐Aniotz, (unknown), Milton Larrondo, Flavio Salazar‐Onfray	3
5	Co-Expression of Immunohistochemical Markers MRP2, CXCR4, and PD-L1 in Gallbladder Tumors Is Associated with Prolonged Patient Survival 2023 ·Cancers ·Andrés Tittarelli, (unknown), (unknown), Anna Bergqvist, Daniel Uribe, (unknown), María Alejandra Gleisner, Jorge R. Vergara, Ignacio Niechi, (unknown), Cristián Pereda, (unknown), (unknown), Flavio Salazar‐Onfray	4
6	C‐type lectin receptors MR and DC‐SIGN are involved in recognition of hemocyanins, shaping their immunostimulatory effects on human dendritic cells 2021 ·European Journal of Immunology ·Javiera Villar, (unknown), José M. Jiménez, (unknown), Augusto Manubens, María Alejandra Gleisner, (unknown), Flavio Salazar‐Onfray, Fabián Salazar, Daniel A. Mitchell, Mohammad Y. Alshahrani, Luisa Martı́nez-Pomares, Marı́a Inés Becker	10
7	Interleukin-8 Secreted by Glioblastoma Cells Induces Microvascular Hyperpermeability Through NO Signaling Involving S-Nitrosylation of VE-Cadherin and p120 in Endothelial Cells 2019 ·Frontiers in Physiology ·(unknown), Patricia Zamorano, (unknown), (unknown), Ángelo Torres, Pamela Ehrenfeld, Mauricio P. Borić, Flavio Salazar‐Onfray, Julie Gavard, Walter N. Durán, Claudia Quezada, José Sarmiento, Fabiola A. Sánchez	16
8	Mind the Gaps in Tumor Immunity: Impact of Connexin-Mediated Intercellular Connections 2017 ·Frontiers in Immunology ·María Alejandra Gleisner, (unknown), (unknown), Flavio Salazar‐Onfray, Andrés Tittarelli	27
9	Molluskan Hemocyanins Activate the Classical Pathway of the Human Complement System through Natural Antibodies 2017 ·Frontiers in Immunology ·(unknown), Ismael Maldonado, (unknown), (unknown), Mercedes López, Flavio Salazar‐Onfray, (unknown), Carolina Valck, Arturo Ferreira, Marı́a Inés Becker	20
10	Melanocortin 1 Receptor-derived peptides are efficiently recognized by cytotoxic T lymphocytes from melanoma patients 2013 ·Immunobiology ·Fermín E. González, Marcos Ramírez, (unknown), (unknown), Andreas Lundqvist, Isabel Poschke, Adnane Achour, Flavio Salazar‐Onfray	6
11	The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses 2012 ·Cancer Immunology Immunotherapy ·Claudia Duran‐Aniotz, (unknown), Lorena Salazar, Cristián Pereda, Cristian R. Falcón, Fabián Tempio, (unknown), (unknown), (unknown), Andrés Tittarelli, Diego Catalán, (unknown), Milton Larrondo, Flavio Salazar‐Onfray, Mercedes López	24
12	Toll-like receptor 4 gene polymorphism influences dendritic cell in vitro function and clinical outcomes in vaccinated melanoma patients 2012 ·Cancer Immunology Immunotherapy ·Andrés Tittarelli, Fermín E. González, Cristián Pereda, G. Mora, (unknown), (unknown), Tamara García‐Salum, David Díaz, Cristian R. Falcón, Marcela A. Hermoso, Mercedes López, Flavio Salazar‐Onfray	32
13	Heat-Shock Induction of Tumor-Derived Danger Signals Mediates Rapid Monocyte Differentiation into Clinically Effective Dendritic Cells 2011 ·Clinical Cancer Research ·(unknown), (unknown), Andrés Tittarelli, Fermín E. González, Marcos Ramírez, Diego Reyes, Cristián Pereda, (unknown), Tamara García‐Salum, Lorena Salazar, Arturo Ferreira, Marcela A. Hermoso, Ariadna Mendoza‐Naranjo, (unknown), (unknown), Mercedes López, Flavio Salazar‐Onfray	70
14	Abstract B17: Heat shock-induced danger signals in tumor cells are crucial for a rapid differentiation of monocyte to therapeutic dendritic cells 2010 ·Clinical Cancer Research ·(unknown), (unknown), Fermín E. González, Andrés Tittarelli, Diego Reyes, (unknown), Mercedes López, Flavio Salazar‐Onfray	1
15	Functional Gap Junctions Facilitate Melanoma Antigen Transfer and Cross-Presentation between Human Dendritic Cells 2007 ·The Journal of Immunology ·Ariadna Mendoza‐Naranjo, Pablo J. Sáez, C. Christian Johansson, Marcos Ramírez, Dinka Mandaković, Cristián Pereda, Mercedes López, Rolf Kiessling, Juan C. Sáez, Flavio Salazar‐Onfray	88
16	Tumour necrosis factor (TNF)α −308 G/G promoter polymorphism and TNFα levels correlate with a better response to adalimumab in patients with rheumatoid arthritis 2006 ·Scandinavian Journal of Rheumatology ·M Cuchacovich, Lilian Soto, M Edwardes, Miguel Ángel Molina Gutiérrez, Carolina Llanos, (unknown), Francisca Sabugo, (unknown), (unknown), (unknown), H Gatica, (unknown), (unknown), Diego Catalán, Olivia Valenzuela, Flavio Salazar‐Onfray, Juan Carlos Aguillón	65
17	The role of regulatory T lymphocytes in the induced immune response mediated by biological vaccines 2006 ·Immunobiology ·Mercedes López, (unknown), (unknown), Ariadna Mendoza‐Naranjo, Cristián Pereda, Marcos Ramírez, (unknown), Juan Carlos Aguillón, Flavio Salazar‐Onfray	29
18	A Synthetic Peptide Homologous to Functional Domain of Human IL-10 Down-Regulates Expression of MHC Class I and Transporter Associated with Antigen Processing 1/2 in Human Melanoma Cells 2004 ·The Journal of Immunology ·Mónica Kurte, Mercedes López, Adam Aguirre, Alejandro Escobar, Juan Carlos Aguillón, Jehad Charo, Christian Grønhøj, Rolf Kiessling, Flavio Salazar‐Onfray	58
19	Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker 2002 ·British Journal of Cancer ·Flavio Salazar‐Onfray, Mercedes López, Andreas Lundqvist, Adam Aguirre, Alejandro Escobar, Antonio E. Serrano, (unknown), Max Petersson, Vijay Chhajlani, Ola Larsson, Rolf Kiessling	98
20	Hydrogen peroxide secreted by tumor‐derived macrophages down‐modulates signal‐transducing zeta molecules and inhibits tumor‐specific T cell‐and natural killer cell‐mediated cytotoxicity 1996 ·European Journal of Immunology ·Koji Kono, Flavio Salazar‐Onfray, Max Petersson, Johan Hansson, Giuseppe Masucci, Ken Wasserman, Tsutomu Nakazawa, Paul Anderson, Rolf Kiessling	301

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact